Patents by Inventor Talapady N. Bhat

Talapady N. Bhat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Knowledge management system and process for managing knowledge
    Patent number: 10872122
    Abstract: A knowledge management system includes: a default knowledge system including: a knowledge system and a knowledge database in communication with the knowledge system; and a knowledge store in communication with the default knowledge system and including: a taxonomy amendment, an annotation amendment, a canonicalization amendment, an ecosystem amendment, a term amendment, and a phrase amendment.
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: December 22, 2020
    Assignee: GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF COMMERCE
    Inventors: John Elliott, Talapady N. Bhat, Ursula R. Kattner, Carelyn E. Campbell, Ram D. Sriram, Eswaran Subrahmanian, Jacob Collard, Ira Monarch
  • KNOWLEDGE MANAGEMENT SYSTEM AND PROCESS FOR MANAGING KNOWLEDGE
    Publication number: 20190236153
    Abstract: A knowledge management system includes: a default knowledge system including: a knowledge system and a knowledge database in communication with the knowledge system; and a knowledge store in communication with the default knowledge system and including: a taxonomy amendment, an annotation amendment, a canonicalization amendment, an ecosystem amendment, a term amendment, and a phrase amendment.
    Type: Application
    Filed: January 30, 2018
    Publication date: August 1, 2019
    Inventors: John Elliott, Talapady N. Bhat, Ursula R. Kattner, Carelyn E. Campbell, Ram D. Sriram, Eswaran Subrahmanian, Jacob Collard, Ira Monarch
  • Retroviral agents containing anthranilamide, substituted benzamide and other subunits, and methods of using same
    Patent number: 5763464
    Abstract: The present invention provides novel retroviral agents containing anthranilamide, substituted benzamide, amino acid, and other subunits, a pharmaceutical composition comprising such compound, and a method of using such compounds to treat retroviral infections in mammals, specifically HIV and more specifically HIV-1 and HIV-2, in humans.
    Type: Grant
    Filed: November 22, 1995
    Date of Patent: June 9, 1998
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Ramnarayan S. Randad, John W. Erickson, Talapadi N. Bhat